Senseonics Holdings Inc
0.0 %
89.43 %
Yet to be announced
Company Overview
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company's primary product is Eversense, a CGM system that includes a small sensor inserted subcutaneously, a smart transmitter worn over the sensor, and a mobile app for displaying glucose values, trends, and alerts.
Revenue Sources
Based on the company's SEC filings and financial statements, Senseonics generates its revenue primarily from the sale of its Eversense CGM systems and related products. The company's revenue streams are derived from legitimate medical devices and services that help diabetic patients monitor their glucose levels. There is no evidence of revenue from prohibited sources.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $4.26m | $29.24m | - | $2.13m | 0.00% | 7.29% |
| June 30, 2024 | $4.87m | $26.44m | - | $2.08m | 0.00% | 7.88% |
| March 31, 2024 | $5.05m | $25.33m | - | $2.05m | 0.00% | 8.08% |
| Dec. 31, 2023 | $8.03m | $26.76m | - | $1.72m | 0.00% | 6.44% |
Examining the last four quarters, the company has consistent interest expenses ranging from $1.7M to $2.1M per quarter, while total expenses range from $25.3M to $29.2M per quarter. Interest expenses represent a material portion of total expenses, averaging around 7-8% of total expenses across the examined periods. This level of interest expense indicates significant reliance on interest-bearing debt.
Operational Ethics
Based on available information from SEC filings and company disclosures, there is no evidence of current material associations with the state of Israel, Chinese Communist Party, or other entities involved in human rights violations. The company's operations are primarily focused in the United States and European markets.
Login to join the discussion